HK1216715A1 - 基於血紅蛋白衍生肽的新型藥物組合物 - Google Patents

基於血紅蛋白衍生肽的新型藥物組合物

Info

Publication number
HK1216715A1
HK1216715A1 HK16104518.7A HK16104518A HK1216715A1 HK 1216715 A1 HK1216715 A1 HK 1216715A1 HK 16104518 A HK16104518 A HK 16104518A HK 1216715 A1 HK1216715 A1 HK 1216715A1
Authority
HK
Hong Kong
Prior art keywords
pharmaceutical compositions
derived peptide
peptide based
based pharmaceutical
novel hemoglobin
Prior art date
Application number
HK16104518.7A
Other languages
English (en)
Inventor
．海尼
．里徹爾
．亞歷山大
．勃蘭登堡
．烏爾默
．馬赫
．戈奇斯基
．霍伊曼
Original Assignee
Clinique La Prairie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Clinique La Prairie filed Critical Clinique La Prairie
Publication of HK1216715A1 publication Critical patent/HK1216715A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/41—Porphyrin- or corrin-ring-containing peptides
    • A61K38/42—Haemoglobins; Myoglobins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/739—Lipopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/795—Porphyrin- or corrin-ring-containing peptides
    • C07K14/805—Haemoglobins; Myoglobins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK16104518.7A 2013-04-11 2016-04-20 基於血紅蛋白衍生肽的新型藥物組合物 HK1216715A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13163414.9A EP2789343A1 (en) 2013-04-11 2013-04-11 Novel hemoglobin-derived peptide based pharmaceutical compositions
PCT/EP2014/057364 WO2014167091A1 (en) 2013-04-11 2014-04-11 Novel hemoglobin-derived peptide based pharmaceutical compositions

Publications (1)

Publication Number Publication Date
HK1216715A1 true HK1216715A1 (zh) 2016-12-02

Family

ID=48050600

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16104518.7A HK1216715A1 (zh) 2013-04-11 2016-04-20 基於血紅蛋白衍生肽的新型藥物組合物

Country Status (7)

Country Link
US (1) US20160184404A1 (zh)
EP (2) EP2789343A1 (zh)
JP (1) JP2016516760A (zh)
CN (1) CN105283200A (zh)
HK (1) HK1216715A1 (zh)
RU (1) RU2015148191A (zh)
WO (1) WO2014167091A1 (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10561712B2 (en) * 2014-05-22 2020-02-18 University Of Maryland, Baltimore Treatment of cancer and inhibition of metastasis using hemoglobin beta subunit
CN105367624A (zh) * 2015-11-25 2016-03-02 刘天军 一种LLVV-Hemorphin-6肽的制备方法和用途
US11174288B2 (en) 2016-12-06 2021-11-16 Northeastern University Heparin-binding cationic peptide self-assembling peptide amphiphiles useful against drug-resistant bacteria
CN107325176B (zh) * 2017-06-16 2020-12-25 神威药业集团有限公司 源于血红蛋白的免疫活性人胎盘多肽

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1481988A3 (de) * 2000-06-08 2005-02-23 IPF PharmaCeuticals GmbH Verfahren zur Gewinnung und Anwendung von antibiotisch wirksamen Peptiden zur Behandlung von Infektionskrankheiten
EP1449535B1 (en) 2003-02-18 2006-05-03 Clinique La Prairie Research SA Compositions comprising fetal hemoglobin and bacterial endotoxin and optionally additional fetal liver components
DK1778271T3 (da) * 2004-08-18 2009-02-16 Ipf Pharmaceuticals Gmbh Peptid til behandling af herpesvirusinfektioner

Also Published As

Publication number Publication date
US20160184404A1 (en) 2016-06-30
EP2789343A1 (en) 2014-10-15
EP2983698A1 (en) 2016-02-17
JP2016516760A (ja) 2016-06-09
CN105283200A (zh) 2016-01-27
WO2014167091A1 (en) 2014-10-16
RU2015148191A (ru) 2017-05-16

Similar Documents

Publication Publication Date Title
IL288961A (en) Pharmaceutical preparations
PT3030262T (pt) Composição farmacêutica de associação
PL2943181T3 (pl) Kompozycje farmaceutyczne
ZA201505966B (en) Peptides and compositions
HK1220697A1 (zh) 肽組合物
PL3043778T3 (pl) Kompozycje farmaceutyczne zawierające refametinib
GB201303771D0 (en) Nanoparticles peptide compositions
ZA201408333B (en) Pharmaceutical compositions
IL243627A (en) High-power pancreatic pharmaceuticals
EP2990038A4 (en) SOLID PHARMACEUTICAL COMPOSITION
IL243435A0 (en) Pharmaceutical preparations of pancreatin with high potency
SG11201601477VA (en) Pharmaceutical composition
PT3061771T (pt) Novo péptido unido a quatro epitopos ctl
HK1216715A1 (zh) 基於血紅蛋白衍生肽的新型藥物組合物
HK1198769A1 (zh) 新型肽
HRP20171888T1 (hr) Farmaceutski pripravci
HUP1300496A2 (hu) Stabil kombinációs gyógyszerkészítmény
IL244956B (en) New peptide compositions
HK1220143A1 (zh) 藥物組合物
GB201303787D0 (en) Nanoparticle peptide compositions
GB201304699D0 (en) Pharmaceutical compositions
GB201321497D0 (en) Pharmaceutical compositions
GB201312851D0 (en) Pharmaceutical compositions
GB201304625D0 (en) New pharmaceutical composition